398 Efficacy and safety of ixekizumab for the treatment of...

398 Efficacy and safety of ixekizumab for the treatment of plaque psoriasis: Results through 108 weeks randomised, phase III clinical trial (UNCOVER-3)

Blauvelt, A., Gooderham, M., Iversen, L., Ball, S., Zhang, L., Agada, N., Reich, K., Dossenbach, M.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
137
Language:
english
Journal:
Journal of Investigative Dermatology
DOI:
10.1016/j.jid.2017.07.593
Date:
October, 2017
File:
PDF, 428 KB
english, 2017
Conversion to is in progress
Conversion to is failed